Northwest Biotherapeutics Inc (NASDAQ:NWBO)

Data as of Jan 23
 +0.02 / +0.32%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Northwest Biotherapeutics, Inc. is a development stage company which is engaged in the development and discovery of innovative immunotherapy products to treat cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

Contact Information

Northwest Biotherapeutics, Inc.
4800 Montgomery Lane
Bethesda Maryland 20814
P:(240) 497-9024
Investor Relations:
(202) 841-7909



Individual stakeholders8.46%
Other institutional6.77%
Mutual fund holders17.42%

Top Executives

Linda F. PowersChairman, President, CEO, CFO & CAO
Alton L. BoyntonChief Scientific Officer, Secretary & Director
Marnix L. BoschChief Technology Officer
Anthony E. MaidaSenior Vice President-Clinical Research
Leslie J. GoldmanSVP-Business Development & Head-Investor Relations

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.